Cigna Group (CI) vs Natera (NTRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Natera (NTRA) has outperformed Cigna Group (CI) over the past year, gaining 134.7% versus a loss of 9.3%. Over five years, NTRA leads with a +257.1% price change compared with +35.1% for CI. Cigna Group is the larger company by market cap ($73.59 billion vs $57.02 billion), about 1.3 times the size, while Natera is growing revenue faster (+35.9% vs +11.2%).
Cigna Group pays a dividend yielding 2.20%, while Natera does not currently pay one. Cigna Group converts more of its revenue into profit, with a net margin of 2.2% versus -9.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CI | NTRA |
|---|---|---|
| Share price | $278.51 | $395.56 |
| Market cap | $73.59B | $57.02B |
| 1-day change | +1.51% | -1.27% |
| YTD return | +1.19% | +72.67% |
| 1-year return | -9.32% | +134.71% |
| 5-year return | +35.07% | +257.10% |
| P/E ratio (TTM) | 11.51 | — |
| Forward P/E | 8.31 | — |
| EPS (TTM) | $24.19 | $-1.33 |
| Dividend yield | 2.20% | 0.00% |
| Annual dividend | $6.14 | $0.00 |
| Revenue (latest FY) | $274.90B | $2.31B |
| Revenue growth (YoY) | +11.24% | +35.90% |
| Net income (latest FY) | $5.96B | $-208.16M |
| Gross margin | 21.79% | — |
| Operating margin | 3.35% | -13.44% |
| Net margin | 2.17% | -9.03% |
| 52-week high | $312.18 | $437.41 |
| 52-week low | $239.51 | $167.99 |
| Distance from 52-week high | -10.79% | -9.57% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +22.90% | -4.58% |
| Average volume | 1.67M | 1.42M |
| Shares outstanding | 264.24M | 144.14M |
| Employees | 65,669 | 6,135 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NTRA has outperformed CI by 144.0 percentage points over the past year.
- Cigna Group offers a meaningfully higher dividend yield (2.20% vs 0.00%).
- Cigna Group is more profitable, keeping 2.2 cents of every revenue dollar as net income versus -9.0 cents for Natera.
- Natera grew revenue faster in its latest fiscal year (+35.90% vs +11.24%).
About Cigna Group
CI stock →The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare.
Health Care · Medical Specialities · 65,669 employees
About Natera
NTRA stock →Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test.
Health Care · Medical Specialities · 6,135 employees
CI vs NTRA FAQ
Which is bigger, Cigna Group or Natera?
Cigna Group (CI) is larger, with a market capitalization of $73.59B compared with $57.02B for Natera (NTRA).
Which stock has performed better over the past year, CI or NTRA?
NTRA returned +134.71% over the past 12 months, compared with -9.32% for CI (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cigna Group or Natera?
Cigna Group pays a dividend yielding 2.20%, while Natera does not currently pay a regular dividend.
Are Cigna Group and Natera in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.